Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Mak Capital One LLC | 33.62M | $53.0M | 12.63% | -- | 2026-06-30 |
| Blackstone Inc. | 20.49M | $32.0M | 7.70% | -- | 2026-06-30 |
| Syncona Portfolio Ltd | 16.64M | $26.0M | 6.25% | -- | 2026-06-30 |
| Armistice Capital, LLC | 15.00M | $24.0M | 5.64% | -800.0K | 2026-06-30 |
| Tetragon Partners GP Ltd | 9.50M | $15.0M | 3.57% | -- | 2026-06-30 |
| Frazier Life Sciences Management, L.P. | 4.45M | $7.0M | 1.67% | -- | 2026-06-30 |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 3.36M | $5.0M | 1.26% | -- | 2026-06-30 |
| Laurion Capital Management LP | 3.32M | $5.0M | 1.25% | -- | 2026-06-30 |
| Renaissance Technologies LLC | 1.98M | $3.0M | 0.75% | -314.8K | 2026-06-30 |
| Bank of America Corp | 1.61M | $2.0M | 0.60% | -239.6K | 2026-06-30 |
